Signaling Receptors for TGF-β Family Members
Open accessAbstract
Transforming growth factor β (TGF-β) family members signal via heterotetrameric complexes of type I and type II dual specificity kinase receptors. The activation and stability of the receptors are controlled by posttranslational modifications, such as phosphorylation, ubiquitylation, sumoylation, and neddylation, as well as by interaction with other proteins at the cell surface and in the cytoplasm. Activation of TGF-β receptors induces signaling via formation of Smad complexes that are translocated to the nucleus where they act as transcription factors, as well as via non-Smad pathways, including the Erk1/2, JNK and p38 MAP kinase pathways, and the Src tyrosine kinase, phosphatidylinositol 3'-kinase, and Rho GTPases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
C-terminal phosphorylation of Smad2 or Smad3 is a marker of TGF-β/Smad signaling, but other TGF-β family members can also cause it.
“Detection of C-terminally phosphorylated Smad2 and/or Smad3 is indicative of TGF-β/Smad signaling, yet may also result from their activation in response to other TGF-β family members, such as activins, myostatin and GDFs65,88.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145 · see citing works
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419 · see citing works
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,130 · see citing works
Smad transcription factorsPreprint
Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,432 · see citing works
Mechanism of activation of the TGF-β receptor
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., & Massagué, J. (1994) · Nature · doi:10.1038/370341a0 · Cited by 2,340 · see citing works
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869 · see citing works
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R. L., Itoh, S., Kawabata, M., Heldin, N., Heldin, C., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,796 · see citing works
Self-citationLosartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794 · see citing works
Loeys, B., Chen, J., Neptune, E., Judge, D. P., Podowski, M., Holm, T. M., Meyers, J. L., Leitch, C. C., Katsanis, N., Sharifi, N., et al. (2005) · Nature Genetics · doi:10.1038/ng1511 · Cited by 1,786 · see citing works
Aneurysm Syndromes Caused by Mutations in the TGF-β Receptor
Loeys, B., Schwarze, U., Holm, T. M., Callewaert, B. L., Thomas, G. H., Pannu, H., Backer, J. F. A. D., Oswald, G. L., Symoens, S., Manouvrier‐Hanu, S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055695 · Cited by 1,650 · see citing works
McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrel, J., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-345 · Cited by 1,475 · see citing works
Targeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466 · see citing works
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H.-Q., Thomsen, G. H., & Wrana, J. (2000) · Molecules and Cells · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,449 · see citing works
Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,322 · see citing works
Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome
Neptune, E., Frischmeyer, P., Arking, D., Myers, L., Bunton, T., Gayraud, B., Ramirez, F., Sakai, L., & Dietz, H. (2003) · Nature Genetics · doi:10.1038/ng1116 · Cited by 1,301 · see citing works
Shore, E. M., Xu, M., Feldman, G. J., Fenstermacher, D., Cho, T., Choi, I. H., Connor, J. M., Delai, P. L. R., Glaser, D. L., Merrer, M. F. L., et al. (2006) · Nature Genetics · doi:10.1038/ng1783 · Cited by 1,215 · see citing works
Distinct endocytic pathways regulate TGF-β receptor signalling and turnover
Guglielmo, G. M. D., Roy, C. L., Goodfellow, A. F., & Wrana, J. L. (2003) · Nature Cell Biology · doi:10.1038/ncb975 · Cited by 1,152 · see citing works
Johnson, D. W., Berg, J. N., Baldwin, M. A., Gallione, C. J., Marondel, I., Yoon, S.-H., Stenzel, T. T., Speer, M. C., Pericak‐Vance, M. A., Diamond, A. G., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-189 · Cited by 1,113 · see citing works
Moustakas, A., & Heldin, C. (2005) · Journal of Cell Science · doi:10.1242/jcs.02554 · Cited by 1,069 · see citing works
Self-citationHe, X., Zhang, J., Tong, W.-G., Tawfik, O. W., Ross, J., Scoville, D. H., Tian, Q., Zeng, X., He, X., Wiedemann, L. M., et al. (2004) · Nature Genetics · doi:10.1038/ng1430 · Cited by 1,065 · see citing works
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · see citing works
Bone morphogenetic protein receptors and signal transduction
Miyazono, K., Kamiya, Y., & Morikawa, M. (2009) · The Journal of Biochemistry · doi:10.1093/jb/mvp148 · Cited by 1,000 · see citing works
SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor
Tsukazaki, T., Chiang, T., Davison, A. F., Attisano, L., & Wrana, J. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81701-8 · Cited by 963 · see citing works
Betaglycan presents ligand to the TGFβ signaling receptor
López‐Casillas, F., Wrana, J. L., & Massagué, J. (1993) · Cell · doi:10.1016/0092-8674(93)90368-z · Cited by 901 · see citing works
Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity
Ozdamar, B., Bose, R., Barrios-Rodiles, M., Wang, H.-R., Zhang, Y., & Wrana, J. L. (2005) · Science · doi:10.1126/science.1105718 · Cited by 881 · see citing works
Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T., & Miyazono, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100008200 · Cited by 845 · see citing works
The regulation of TGFβ signal transduction
Moustakas, A., & Heldin, C. (2009) · Development · doi:10.1242/dev.030338 · Cited by 830 · see citing works
Self-citationExtracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 777 · see citing works
Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis
Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J., Cheung, P., Granovsky, M., Nabi, I. R., Wrana, J. L., & Dennis, J. W. (2004) · Science · doi:10.1126/science.1102109 · Cited by 735 · see citing works
Silencing of TGF-β signalling by the pseudoreceptor BAMBI
Onichtchouk, D., Chen, Y., Dosch, R., Gawantka, V., Delius, H., Massagué, J., & Niehrs, C. (1999) · Nature · doi:10.1038/46794 · Cited by 727 · see citing works
High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells
Barrios‐Rodiles, M., Brown, K. R., Ozdamar, B., Bose, R., Liu, Z., Donovan, R. S., Shinjo, F., Liu, Y., Dembowy, J., Taylor, I. W., et al. (2005) · Science · doi:10.1126/science.1105776 · Cited by 726 · see citing works
David, L., Mallet, C., Mazerbourg, S., Feige, J., & Bailly, S. (2006) · Blood · doi:10.1182/blood-2006-07-034124 · Cited by 708 · see citing works
Activin Receptor-like Kinase (ALK)1 Is an Antagonistic Mediator of Lateral TGFβ/ALK5 Signaling
Goumans, M.-J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S., & ten Dijke, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00386-1 · Cited by 689 · see citing works
López‐Casillas, F., Cheifetz, S., Doody, J. F., Andres, J., Lane, W. S., & Massagué, J. (1991) · Cell · doi:10.1016/0092-8674(91)90073-8 · Cited by 676 · see citing works
Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction
Lebrin, F., Goumans, M., Jonker, L., Carvalho, R. L. C., Valdimarsdóttir, G., Thorikay, M., Mummery, C. L., Arthur, H. M., & ten Dijke, P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600386 · Cited by 653 · see citing works
Buczkowicz, P., Hoeman, C. M., Rakopoulos, P., Pajovic, S., Létourneau, L., Dzamba, M., Morrison, A., Lewis, P. W., Bouffet, É., Bartels, U. K., et al. (2014) · Nature Genetics · doi:10.1038/ng.2936 · Cited by 649 · see citing works
Razani, B., Zhang, X. L., Bitzer, M., von Gersdorff, G., Böttinger, E. P., & Lisanti, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008340200 · Cited by 640 · see citing works
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis
Howe, J. R., Bair, J. L., Sayed, M. G., Anderson, M. E., Mitros, F. A., Petersen, G. M., Velculescu, V. E., Traverso, G., & Vogelstein, B. (2001) · Nature Genetics · doi:10.1038/88919 · Cited by 630 · see citing works
Heterozygous TGFBR2 mutations in Marfan syndrome
Mizuguchi, T., Collod‐Béroud, G., Akiyama, T., Abifadel, M., Harada, N., Morisaki, T., Allard, D., Varret, M., Claustres, M., Morisaki, H., et al. (2004) · Nature Genetics · doi:10.1038/ng1392 · Cited by 627 · see citing works
Subramanyam, D., Lamouille, S., Judson, R. L., Liu, J. Y., Bucay, N., Derynck, R., & Blelloch, R. H. (2011) · Nature Biotechnology · doi:10.1038/nbt.1862 · Cited by 594 · see citing works
Betaglycan binds inhibin and can mediate functional antagonism of activin signalling
Lewis, K. A., Gray, P. C., Blount, A. L., MacConell, L., Wiater, E., Bilezikjian, L. M., & Vale, W. (2000) · Nature · doi:10.1038/35006129 · Cited by 585 · see citing works
TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA
Lee, M. K., Pardoux, C., Hall, M. C., Lee, P. S., Warburton, D., Qing, J., Smith, S. M., & Derynck, R. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601818 · Cited by 580 · see citing works
Nohe, A., Haßel, S., Ehrlich, M., Neubauer, F. B., Sebald, W., Henis, Y. I., & Knaus, P. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m102750200 · Cited by 566 · see citing works
Pece-Barbara, N., Wrana, J. L., & Letarte, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.584 · Cited by 564 · see citing works
TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-β
Yamashita, M., Fátyol, K., Jin, C., Wang, X., Liu, Z.-G., & Zhang, Y. E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.002 · Cited by 559 · see citing works
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Sorrentino, A., Thakur, N., Grimsby, S., Marcusson, A., von Bülow, V., Schuster, N., Zhang, S., Heldin, C., & Landström, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1780 · Cited by 553 · see citing works
Self-citationDevelopment of TGF-β signalling inhibitors for cancer therapy
Yingling, J. M., Blanchard, K. L., & Sawyer, J. S. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1580 · Cited by 550 · see citing works
BMPR2 Haploinsufficiency as the Inherited Molecular Mechanism for Primary Pulmonary Hypertension
Machado, R. D., Pauciulo, M. W., Thomson, J. R., Lane, K. B., Morgan, N. V., Wheeler, L. A., Phillips, J. A., III, Newman, J. H., Williams, D., Galiè, N., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316947 · Cited by 535 · see citing works
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Taylor, K. R., Mackay, A. G., Truffaux, N., Butterfield, Y. S. N., Morozova, O., Philippe, C., Castel, D., Grasso, C. S., Vinci, M., Carvalho, D. M., et al. (2014) · Nature Genetics · doi:10.1038/ng.2925 · Cited by 522 · see citing works
Abdollah, S., Macías‐Silva, M., Tsukazaki, T., Hayashi, H., Attisano, L., & Wrana, J. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27678 · Cited by 481 · see citing works
FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension
Spiekerkoetter, E. F., Tian, X., Cai, J., Hopper, R. K., Sudheendra, D., Li, C. G., El‐Bizri, N., Sawada, H., Haghighat, R., Chan, R., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65592 · Cited by 449 · see citing works
Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12
Huse, M., Chen, Y., Massagué, J., & Kuriyan, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80555-3 · Cited by 446 · see citing works
Hatsell, S. J., Idone, V., Wolken, D. M. A., Huang, L., Kim, H. J., Wang, L., Wen, X., Nannuru, K. C., Jimenez, J., Xie, L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4358 · Cited by 446 · see citing works
Universal GFP reporter for the study of vascular development
Motoike, T., Loughna, S., Perens, E. A., Roman, B. L., Liao, W., Chau, T. C., Richardson, C. D., Kawate, T., Kuno, J., Weinstein, B. M., et al. (2000) · genesis · doi:10.1002/1526-968x(200010)28:2 · Cited by 446 · see citing works
Arthur, H. M., Ure, J. M., Smith, A. J. H., Renforth, G. L., Wilson, D. I., Torsney, E., Charlton, R., Parums, D. V., Jowett, T., Marchuk, D. A., et al. (2000) · Developmental Biology · doi:10.1006/dbio.1999.9534 · Cited by 436 · see citing works
Kaplan, F. S., Xu, M., Seemann, P., Connor, J. M., Glaser, D. L., Carroll, L., Delai, P. L. R., Fastnacht-Urban, E., Forman, S. J., Gillessen‐Kaesbach, G., et al. (2008) · Human Mutation · doi:10.1002/humu.20868 · Cited by 436 · see citing works
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Huang, S., Hölzel, M., Knijnenburg, T., Schlicker, A., Roepman, P., McDermott, U., Garnett, M., Grernrum, W., Sun, C., Prahallad, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.035 · Cited by 430 · see citing works
Brock, M., Trenkmann, M., Gay, R., Michel, B., Gay, S., Fischler, M., Ulrich, S., Speich, R., & Huber, L. (2009) · Circulation Research · doi:10.1161/circresaha.109.197491 · Cited by 422 · see citing works
Uhl, M., Aulwurm, S., Wischhusen, J., Weiler, M., Jing, Y., Almirez, R. G., Mangadu, R., Liu, Y.-W., Platten, M., Herrlinger, U., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1013 · Cited by 414 · see citing works
Eichhorn, P. J. A., Rodón, L., Gonzàlez-Juncà, A., Dirac, A., Gili, M., Martínez-Sáez, E., Aura, C., Barba, I., Peg, V., Prat, A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2619 · Cited by 409 · see citing works
Fibrodysplasia ossificans progressiva
Kaplan, F. S., Merrer, M. F. L., Glaser, D. L., Pignolo, R. J., Goldsby, R. E., Kitterman, J. A., Groppe, J. C., & Shore, E. M. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.11.007 · Cited by 394 · see citing works
López‐Casillas, F., Payne, H., Andres, J., & Massagué, J. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.557 · Cited by 393 · see citing works
The Immunophilin FKBP12 Functions as a Common Inhibitor of the TGFβ Family Type I Receptors
Wang, T., Li, B.-Y., Danielson, P. D., Shah, P. C., Rockwell, S., Lechleider, R. J., Martin, J. M., Manganaro, T. F., & Donahoe, P. K. (1996) · Cell · doi:10.1016/s0092-8674(00)80116-6 · Cited by 388 · see citing works
Souchelnytskyi, S., Tamaki, K., Engström, U., Wernstedt, C., ten Dijke, P., & Heldin, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.28107 · Cited by 382 · see citing works
Self-citationThe TGFβ Receptor Activation Process
Huse, M., Muir, T. W., Xu, L., Chen, Y., Kuriyan, J., & Massagué, J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00332-x · Cited by 381 · see citing works
Beyond TGFβ: roles of other TGFβ superfamily members in cancer
Wakefield, L. M., & Hill, C. S. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3500 · Cited by 373 · see citing works
Pannu, H., Tran‐Fadulu, V., Chang, J., Lafont, A. L., Hasham, S. N., Sparks, E. A., Giampietro, P. F., Zaleski, C. A., Estrera, A. L., Safi, H. J., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.537340 · Cited by 368 · see citing works
Phospho-control of TGF-β superfamily signaling
Wrighton, K. H., Lin, X., & Feng, X. (2008) · Cell Research · doi:10.1038/cr.2008.327 · Cited by 366 · see citing works
Mechanism of TGFβ receptor inhibition by FKBP12
Chen, Y., Liu, F., & Massagué, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3866 · Cited by 363 · see citing works
Kowanetz, M., Valcourt, U., Bergström, R., Heldin, C., & Moustakas, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4241-4254.2004 · Cited by 346 · see citing works
Self-citationEndogenous TGF‐β signaling suppresses maturation of osteoblastic mesenchymal cells
Maeda, S., Hayashi, M., Komiya, S., Imamura, T., & Miyazono, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600067 · Cited by 339 · see citing works
Liu, J., Liao, S., Diop-Frimpong, B., Chen, W., Goel, S., Naxerova, K., Ancukiewicz, M., Boucher, Y., Jain, R. K., & Xu, L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117610109 · Cited by 332 · see citing works
Yamashita, H., ten Dijke, P., Franzèn, P., Miyazono, K., & Heldin, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32142-7 · Cited by 326 · see citing works
Self-citationDirect signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1
Foletta, V. C., Lim, M. A., Soosairajah, J., Kelly, A. P., Stanley, E. G., Shannon, M., He, W., Das, S., Massagué, J., & Bernard, O. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212060 · Cited by 325 · see citing works
Crystal structure of the BMP-2–BRIA ectodomain complex
Kirsch, T., Sebald, W., & Dreyer, M. (2000) · Nature Structural Biology · doi:10.1038/75903 · Cited by 323 · see citing works
USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor
Zhang, L., Zhou, F., Drabsch, Y., Gao, R., Snaar-Jagalska, E. B., Mickanin, C., Huang, H., Sheppard, K.-A., Porter, J. A., Lu, C., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2522 · Cited by 322 · see citing works
The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-β Pathway in Neuroblastoma
Mestdagh, P., Boström, A.-K., Impens, F., Fredlund, E., Van Peer, G., De Antonellis, P., von Stedingk, K., Ghesquière, B., Schulte, S., Dews, M., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.11.038 · Cited by 314 · see citing works
Cytoplasmic PML function in TGF-β signalling
Lin, H., Bergmann, S., & Pandolfi, P. P. (2004) · Nature · doi:10.1038/nature02783 · Cited by 312 · see citing works
TGFβ receptor internalization into EEA1-enriched early endosomes
Hayes, S., Chawla, A., & Corvera, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204088 · Cited by 301 · see citing works
Groppe, J. C., Hinck, C. S., Samavarchi‐Tehrani, P., Zubieta, C., Schuermann, J. P., Taylor, A. B., Schwarz, P. M., Wrana, J. L., & Hinck, A. P. (2008) · Molecular Cell · doi:10.1016/j.molcel.2007.11.039 · Cited by 284 · see citing works
Smad6 Is a Smad1/5-induced Smad Inhibitor
Ishida, W., Hamamoto, T., Kusanagi, K., Yagi, K., Kawabata, M., Takehara, K., Sampath, T. K., Kato, M., & Miyazono, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6075 · Cited by 282 · see citing works
Daly, A. C., Randall, R. A., & Hill, C. S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01192-08 · Cited by 280 · see citing works
Keklikoglou, I., Körner, C., Schmidt, C., Zhang, J. D., Heckmann, D., Shavinskaya, A., Allgayer, H., Gückel, B., Fehm, T. N., Schneeweiß, A., et al. (2011) · Oncogene · doi:10.1038/onc.2011.571 · Cited by 273 · see citing works
GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor
Shi, W., Sun, C., He, B., Xiong, W., Shi, X., Yao, D., & Cao, X. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307151 · Cited by 267 · see citing works
Yang, H., Fang, F., Chang, R., & Yang, L.-Y. (2013) · Hepatology · doi:10.1002/hep.26315 · Cited by 267 · see citing works
Lo, R. S., Chen, Y., Shi, Y., Pavletich, N. P., & Massagué, J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.996 · Cited by 266 · see citing works
Howe, J. R., Sayed, M. G., Ahmed, A. F., Ringold, J., Larsen-Haidle, J., Merg, A., Mitros, F. A., Vaccaro, C. A., Petersen, G. M., Giardiello, F. M., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.018598 · Cited by 266 · see citing works
MicroRNA-21 Integrates Pathogenic Signaling to Control Pulmonary Hypertension
Parikh, V. N., Jin, R. C., Rabello, S., Gulbahce, N., White, K., Hale, A., Cottrill, K. A., Shaik, R. S., Waxman, A. B., Zhang, Y., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.060269 · Cited by 264 · see citing works
ß-Arrestin 2 Mediates Endocytosis of Type III TGF-ß Receptor and Down-Regulation of Its Signaling
Chen, W., Kirkbride, K. C., How, T., Nelson, C. D., Mo, J., Frederick, J. P., Wang, X., Lefkowitz, R. J., & Blobe, G. C. (2003) · Science · doi:10.1126/science.1083195 · Cited by 258 · see citing works
Galliher, A. J., & Schiemann, W. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3851 · Cited by 249 · see citing works
Zhang, M., Kleber, S., Röhrich, M., Timke, C., Han, N., Tuettenberg, J., Martin-Villalba, A., Debus, J., Peschke, P., Wirkner, U., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1212 · Cited by 249 · see citing works
The adaptor molecule Disabled‐2 links the transforming growth factor β receptors to the Smad pathway
Hocevar, B. A., Smine, A., Xu, X., & Howe, P. H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2789 · Cited by 248 · see citing works
The type III TGF-β receptor suppresses breast cancer progression
Dong, M., How, T., Kirkbride, K. C., Gordon, K. J., Lee, J. D., Hempel, N., Kelly, P., Moeller, B. J., Marks, J. R., & Blobe, G. C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29293 · Cited by 246 · see citing works
Stenvers, K. L., Tursky, M. L., Harder, K. W., Kountouri, N., Amatayakul‐Chantler, S., Grail, D., Small, C. G., Weinberg, R. A., Sizeland, A. M., & Zhu, H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4371-4385.2003 · Cited by 239 · see citing works
Galliher, A. J., & Schiemann, W. P. (2006) · Breast Cancer Research · doi:10.1186/bcr1524 · Cited by 236 · see citing works
Rodon, J. A., Carducci, M. A., Sepúlveda-Sánchez, J. M., Azaro, A., Calvo, E., Seoane, J., Braña, I., Sicart, E., Gueorguieva, I., Cleverly, A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1380 · Cited by 235 · see citing works
Role of TAK1 and TAB1 in BMP signaling in early Xenopus development
Shibuyà, H., Iwata, H., Masuyama, N., Gotoh, Y., Yamaguchi, K., Irie, K., Matsumoto, K., Nishida, E., & Ueno, N. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.1019 · Cited by 230 · see citing works
Type I Transforming Growth Factor β Receptor Binds to and Activates Phosphatidylinositol 3-Kinase
Yi, J. Y., Shin, I., & Arteaga, C. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413223200 · Cited by 228 · see citing works
DRAGON, a Bone Morphogenetic Protein Co-receptor
Samad, T. A., Rebbapragada, A., Bell, E. J. D. H., Zhang, Y. E., Sidis, Y., Jeong, S., Campagna, J. A., Perusini, S. J., Fabrizio, D. A., Schneyer, A. L., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410034200 · Cited by 228 · see citing works
Park, S. O., Lee, Y. J., Seki, T., Hong, K., Fliess, N., Jiang, Z.-G., Park, A., Wu, X., Kaartinen, V., Roman, B. L., et al. (2007) · Blood · doi:10.1182/blood-2007-08-107359 · Cited by 227 · see citing works
Bourguignon, L., Singleton, P. A., Zhu, H., & Zhou, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204320200 · Cited by 224 · see citing works
TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis
Zhang, L., Zhou, F., de Vinuesa, A. G., de Kruijf, E. M., Mesker, W. E., Li, H., Drabsch, Y., Li, Y., Bauer, A., Rousseau, A., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.014 · Cited by 224 · see citing works
TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G<sub>1</sub> arrest
Petritsch, C., Beug, H., Balmain, A., & Oft, M. (2000) · Genes & Development · doi:10.1101/gad.854200 · Cited by 223 · see citing works
TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases
Mohammad, K. S., Javelaud, D., Fournier, P. G. J., Niewolna, M., McKenna, C. R., Peng, X., Duong, V. H., Dunn, L. K., Mauviel, A., & Guise, T. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2651 · Cited by 221 · see citing works
Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP‐dependent dendritogenesis
Lee-Hoeflich, S. T., Causing, C. G., Podkowa, M., Zhao, X., Wrana, J. L., & Attisano, L. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600418 · Cited by 220 · see citing works
Guerrero-Esteo, M., Sánchez-Elsner, T., Letamendı́a, A., & Bernabéu, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111991200 · Cited by 219 · see citing works
Mitchell, H., Choudhury, A., Pagano, R. E., & Leof, E. B. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-03-0245 · Cited by 215 · see citing works
Ferrigno, O., Lallemand, F., Verrecchia, F., L'Hoste, S., Camonis, J., Atfi, A., & Mauviel, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205623 · Cited by 215 · see citing works
Crystal structure of the human TβR2 ectodomain–TGF-β3 complex
Hart, P. J., Deep, S., Taylor, A. B., Shu, Z., Hinck, C. S., & Hinck, A. P. (2002) · Nature Structural Biology · doi:10.1038/nsb766 · Cited by 214 · see citing works
Ski and SnoN: negative regulators of TGF-β signaling
Luo, K. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.003 · Cited by 214 · see citing works
Feng, X., & Derynck, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3912 · Cited by 211 · see citing works
Dual Roles of Cripto as a Ligand and Coreceptor in the Nodal Signaling Pathway
Yan, Y., Liu, J.-J., Luo, Y., Chaosu, E., Haltiwanger, R. S., Abate-Shen, C. T., & Shen, M. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4439-4449.2002 · Cited by 209 · see citing works
The types II and III transforming growth factor-beta receptors form homo-oligomers.
Henis, Y. I., Moustakas, A., Lin, H. Y.-F., & Lodish, H. F. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.1.139 · Cited by 205 · see citing works
Self-citationChan, M. C., Hilyard, A. C., Wu, C., Davis‐Dusenbery, B. N., Hill, N. S., Lal, A., Lieberman, J., Lagna, G., & Hata, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.370 · Cited by 200 · see citing works
Lin, M., Sutherland, D. R., Horsfall, W., Totty, N. F., Yeo, E. L., Nayar, R., Wu, X., & Schuh, A. C. (2002) · Blood · doi:10.1182/blood.v99.5.1683 · Cited by 199 · see citing works
TGFBR1andTGFBR2mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome
Singh, K. K., Rommel, K., Mishra, A., Karck, M., Haverich, A., Schmidtke, J., & Arslan‐Kirchner, M. (2006) · Human Mutation · doi:10.1002/humu.20354 · Cited by 198 · see citing works
MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4
Wang, Q., Huang, Z., Xue, H., Jin, C., Ju, X., Han, J. J., & Chen, Y. (2007) · Blood · doi:10.1182/blood-2007-05-092718 · Cited by 198 · see citing works
Bone Morphogenetic Proteins Signal through the Transforming Growth Factor-β Type III Receptor
Kirkbride, K. C., Townsend, T. A., Bruinsma, M. W., Barnett, J. V., & Blobe, G. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704883200 · Cited by 194 · see citing works
USP15 is a deubiquitylating enzyme for receptor-activated SMADs
Inui, M., Manfrin, A., Mamidi, A., Martello, G., Morsut, L., Soligo, S., Enzo, E., Moro, S., Polo, S., Dupont, S., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2346 · Cited by 193 · see citing works
Penheiter, S. G., Mitchell, H. D., Garamszegi, N., Edens, M., Doré, J. J. E., & Leof, E. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4750-4759.2002 · Cited by 188 · see citing works
Glinka, Y., Stoilova, S., Mohammed, N., & Prud'homme, G. (2011) · Carcinogenesis · doi:10.1093/carcin/bgq281 · Cited by 186 · see citing works
MicroRNA control of Nodal signalling
Martello, G., Zacchigna, L., Inui, M., Montagner, M., Adorno, M., Mamidi, A., Morsut, L., Soligo, S., Tran, U., Dupont, S., et al. (2007) · Nature · doi:10.1038/nature06100 · Cited by 185 · see citing works
Bandyopadhyay, A. M., Agyin, J. K., Wang, L., Tang, Y., Lei, X., Story, B. M., Cornell, J. E., Pollock, B. H., Mundy, G. R., & Sun, L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3565 · Cited by 185 · see citing works
Emergence, development and diversification of the TGF-β signalling pathway within the animal kingdom
Huminiecki, Ł., Goldovsky, L., Freilich, S., Moustakas, A., Ouzounis, C. A., & Heldin, C. (2009) · BMC Evolutionary Biology · doi:10.1186/1471-2148-9-28 · Cited by 183 · see citing works
Self-citationChaikuad, A., Alfano, I., Kerr, G., Sanvitale, C., Boergermann, J. H., Triffitt, J. T., von Delft, F., Knapp, S., Knaus, P. I., & Bullock, A. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365932 · Cited by 182 · see citing works
TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer
Mu, Y., Sundar, R., Thakur, N., Ekman, M., Gudey, S. K., Yakymovych, M., Hermansson, A., Dimitriou, H., Bengoechea-Alonso, M. T., Ericsson, J., et al. (2011) · Nature Communications · doi:10.1038/ncomms1332 · Cited by 182 · see citing works
Self-citationMoustakas, A., Lin, H. Y.-F., Henis, Y. I., Plamondon, J., O'Connor‐McCourt, M. D., & Lodish, H. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41509-8 · Cited by 181 · see citing works
Self-citationEhata, S., Hanyu, A., Fujime, Μ., Katsuno, Y., Fukunaga, E., Goto, K., Ishikawa, Y., Nomura, K., Yokoo, H., Shimizu, T., et al. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00357.x · Cited by 181 · see citing works
Cunha, S. I., Pardali, E., Thorikay, M., Anderberg, C., Hawinkels, L. J. A. C., Goumans, M., Seehra, J. S., Heldin, C., ten Dijke, P., & Pietras, K. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091309 · Cited by 177 · see citing works
Self-citationWang, B., Jha, J. C., Hagiwara, S., McClelland, A., Jandeleit-Dahm, K. A. M., Thomas, M. C., Cooper, M. E., & Kantharidis, P. (2013) · Kidney International · doi:10.1038/ki.2013.372 · Cited by 175 · see citing works
Oved, S., Mosesson, Y., Zwang, Y., Santonico, E., Shtiegman, K., Marmor, M. D., Kochupurakkal, B. S., Katz, M., Lavi, S., Cesareni, G., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513034200 · Cited by 175 · see citing works
Liu, I. M., Schilling, S. H., Knouse, K. A., Choy, L., Derynck, R., & Wang, X. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.266 · Cited by 174 · see citing works
STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling
Datta, P. K., & Moses, H. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3157-3167.2000 · Cited by 174 · see citing works
Alk1 and Alk5 inhibition by Nrp1 controls vascular sprouting downstream of Notch
Aspalter, I. M., Gordon, E. J., Dubrac, A., Ragab, A., Narloch, J., Vizán, P., Geudens, I., Collins, R., Franco, C. A., Abrahams, C. L., et al. (2015) · Nature Communications · doi:10.1038/ncomms8264 · Cited by 170 · see citing works
Essential Role of TGF-β Signaling in Glucose-Induced Cell Hypertrophy
Wu, L., & Derynck, R. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.05.010 · Cited by 167 · see citing works
van Dinther, M., Visser, N. A. H., de Gorter, D. J. J., Doorn, J., Goumans, M., de Boer, J., & ten Dijke, P. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091110 · Cited by 167 · see citing works
Radaev, S., Zou, Z., Huang, T., Lafer, E. M., Hinck, A. P., & Sun, P. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079921 · Cited by 165 · see citing works
Mythreye, K., & Blobe, G. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812879106 · Cited by 165 · see citing works
Weis‐Garcia, F., & Massagué, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00358.x · Cited by 158 · see citing works
Zeng, Y. C., Qu, X., Li, H., HUANG, S. H., Wang, S., Xu, Q., Lin, R., Han, Q., Li, J., & Zhao, R. C. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.049 · Cited by 158 · see citing works
c-Cbl-Mediated Neddylation Antagonizes Ubiquitination and Degradation of the TGF-β Type II Receptor
Zuo, W., Huang, F., Chiang, Y. J., Li, M., Du, J. C., Ding, Y., Zhang, T., Lee, H. W., Jeong, L. S., Chen, Y., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.12.002 · Cited by 157 · see citing works
VE‐cadherin is a critical endothelial regulator of TGF‐β signalling
Rudini, N., Felici, A., Giampietro, C., Lampugnani, M. G., Corada, M., Swirsding, K., Garrè, M., Liebner, S., Letarte, M., ten Dijke, P., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.46 · Cited by 157 · see citing works
TGF-β type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling
Qiu, T., Wu, X., Zhang, F., Clemens, T. L., Wan, M., & Cao, X. (2010) · Nature Cell Biology · doi:10.1038/ncb2022 · Cited by 156 · see citing works
Ge, R., Rajeev, V., Ray, P., Lattime, E. C., Rittling, S. R., Medicherla, S., Protter, A., Murphy, A., Chakravarty, J., Dugar, S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0162 · Cited by 154 · see citing works
Arabidopsis kinome: after the casting
Champion, A., Kreis, M. E., Mockaitis, K., Picaud, A., & Henry, Y. (2004) · Functional & Integrative Genomics · doi:10.1007/s10142-003-0096-4 · Cited by 151 · see citing works
Chen, T., Carter, D., Garrigue‐Antar, L., & Reiss, M. (1998) · PubMed · Cited by 150 · see citing works
Sorensen, L. K., Brooke, B. S., Li, D. Y., & Urness, L. D. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00158-1 · Cited by 150 · see citing works
TAK1 is an essential regulator of BMP signalling in cartilage
Shim, J., Greenblatt, M. B., Xie, M., Schneider, M. D., Zou, W., Zhai, B., Gygi, S. P., & Glimcher, L. H. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.162 · Cited by 150 · see citing works
Betaglycan Inhibits TGF-β Signaling by Preventing Type I-Type II Receptor Complex Formation
Eickelberg, O., Reiß, M., Kashgarian, M. J., & Wells, R. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105110200 · Cited by 149 · see citing works
Signals and ReceptorsPreprint
Heldin, C., Lu, B. C., Evans, R. M., & Gutkind, J. S. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005900 · Cited by 148 · see citing works
Self-citationMolecular recognition in bone morphogenetic protein (BMP)/receptor interaction
Sebald, W., Nickel, J., Zhang, J., & Mueller, T. D. (2004) · Biological Chemistry · doi:10.1515/bc.2004.086 · Cited by 146 · see citing works
Selective Inhibitory Effects of Smad6 on Bone Morphogenetic Protein Type I Receptors
Goto, K., Kamiya, Y., Imamura, T., Miyazono, K., & Miyazawa, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702100200 · Cited by 145 · see citing works
Human BAMBI Cooperates with Smad7 to Inhibit Transforming Growth Factor-β Signaling
Yan, X., Lin, Z., Chen, F., Zhao, X., Chen, H., Ning, Y., & Chen, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049304 · Cited by 144 · see citing works
Identification of CD109 as part of the TGF‐β receptor system in human keratinocytes
Finnson, K. W., Tam, B. Y. Y., Liu, K., Marcoux, A., Lepage, P., Roy, S., Bizet, A. A., & Philip, A. (2006) · The FASEB Journal · doi:10.1096/fj.05-5229fje · Cited by 142 · see citing works
The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptors
Bizet, A. A., Liu, K., Tran‐Khanh, N., Saksena, A., Vorstenbosch, J., Finnson, K. W., Buschmann, M. D., & Philip, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.028 · Cited by 141 · see citing works
The type I TGF-β receptor is covalently modified and regulated by sumoylation
Kang, J. S., Saunier, E. F., Akhurst, R. J., & Derynck, R. (2008) · Nature Cell Biology · doi:10.1038/ncb1728 · Cited by 141 · see citing works
TACE-Mediated Ectodomain Shedding of the Type I TGF-β Receptor Downregulates TGF-β Signaling
Liu, C., Xu, P., Lamouille, S., Xu, J., & Derynck, R. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.018 · Cited by 140 · see citing works
Sætrom, P., Biesinger, J., Li, S. M., Smith, D., Thomas, L. F., Majzoub, K., Rivas, G. E., Alluin, J., Rossi, J. J., Krontiris, T. G., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1201 · Cited by 138 · see citing works
Gilboa, L., Wells, R. G., Lodish, H. F., & Henis, Y. I. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.767 · Cited by 138 · see citing works
Identification of STRAP, a Novel WD Domain Protein in Transforming Growth Factor-β Signaling
Datta, P. K., Chytil, A. M., Gorska, A. E., & Moses, H. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34671 · Cited by 138 · see citing works
Homomeric interactions between type II transforming growth factor-beta receptors.
Chen, R., & Derynck, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31725-8 · Cited by 137 · see citing works
MicroRNA-30c promotes human adipocyte differentiation and co-represses PAI-1 and ALK2
Karbiener, M., Neuhold, C., Opriessnig, P., Prokesch, A., Bogner-Strauss, J., & Scheideler, M. (2011) · RNA Biology · doi:10.4161/rna.8.5.16153 · Cited by 136 · see citing works
The TGFβ activated kinase TAK1 regulates vascular development in vivo
Jadrich, J. L., O’Connor, M. B., & Coucouvanis, E. C. (2006) · Development · doi:10.1242/dev.02333 · Cited by 134 · see citing works
Chan, M. C., Nguyen, P. H., Davis‐Dusenbery, B. N., Ohoka, N., Hayashi, H., Du, K., Lagna, G., & Hata, A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00218-07 · Cited by 134 · see citing works
Ye, G., Fu, G., Cui, S., Zhao, S., Bernaudo, S., Bai, Y., Ding, Y., Zhang, Y., Yang, B. B., & Peng, C. (2011) · Journal of Cell Science · doi:10.1242/jcs.072223 · Cited by 134 · see citing works
Wrighton, K. H., Lin, X., Yu, P. B., & Feng, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809223200 · Cited by 133 · see citing works
Souchelnytskyi, S., ten Dijke, P., Miyazono, K., & Heldin, C. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01013.x · Cited by 132 · see citing works
Self-citationCritical regulation of TGFβ signaling by Hsp90
Wrighton, K. H., Lin, X., & Feng, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800163105 · Cited by 131 · see citing works
Lawler, S. E., Feng, X., Chen, R., Maruoka, E. M., Turck, C. W., Griswold‐Prenner, I., & Derynck, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14850 · Cited by 131 · see citing works
Siragam, V., Rutnam, Z. J., Yang, W., Fang, L., Luo, L., Yang, X., Li, M., Deng, Z., Qian, J., Peng, C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.717 · Cited by 130 · see citing works
Transforming Growth Factor-β Receptors Interact with AP2 by Direct Binding to β2 Subunit
Yao, D., Ehrlich, M., Henis, Y. I., & Leof, E. B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-07-0104 · Cited by 129 · see citing works
Xi, Q., He, W., Zhang, X. H.-F., Le, H.-V., & Massagué, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707479200 · Cited by 129 · see citing works
Griswold‐Prenner, I., Kamibayashi, C., Maruoka, E. M., Mumby, M. C., & Derynck, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6595 · Cited by 127 · see citing works
MicroRNA-181a Suppresses Mouse Granulosa Cell Proliferation by Targeting Activin Receptor IIA
Zhang, Q., Sun, H., Jiang, Y., Ding, L., Wu, S., Fang, T., Yan, G., & Hu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059667 · Cited by 127 · see citing works
Luo, K., & Lodish, H. F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1970 · Cited by 126 · see citing works
Senanayake, U., Das, S. K., Vesely, P. W., Zoughbi, W. A., Fröhlich, L. F., Chowdhury, P., Leuschner, I., Höefler, G., & Guertl, B. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs126 · Cited by 125 · see citing works
Zhong, Z., Carroll, K. D., Policarpio, D., Osborn, C., Gregory, M., Bassi, R., Jimenez, X., Prewett, M., Liebisch, G., Persaud, K., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1634 · Cited by 123 · see citing works
Single-molecule imaging reveals transforming growth factor-β-induced type II receptor dimerization
Zhang, W., Jiang, Y., Wang, Q., Ma, X., Xiao, Z., Zuo, W., Fang, X., & Chen, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908279106 · Cited by 122 · see citing works
Velasco, S., Álvarez-Muñoz, P., Pericacho, M., ten Dijke, P., Bernabéu, C., López-Novoa, J. M., & Rodríguez‐Barbero, A. (2008) · Journal of Cell Science · doi:10.1242/jcs.023283 · Cited by 119 · see citing works
TGF‐β signalling is mediated by two autonomously functioning TβRI:TβRII pairs
Huang, T., David, L., Mendoza, V., Yang, Y., Villarreal, M. M., De, K., Sun, L., Fang, X., López‐Casillas, F., Wrana, J. L., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.54 · Cited by 119 · see citing works
Atfi, A., Dumont, E., Colland, F., Bonnier, D., L’Helgoualc’h, A., Prunier, C., Ferrand, N., Clément, B., Wewer, U. M., & Théret, N. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612046 · Cited by 119 · see citing works
Lee, N. Y., Ray, B. N., How, T., & Blobe, G. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803059200 · Cited by 117 · see citing works
Bambi is coexpressed with Bmp-4 during mouse embryogenesis
Grotewold, L., Plum, M., Dildrop, R., Peters, T., & Rüther, U. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00524-4 · Cited by 114 · see citing works
Suzuki, E., Kim, S., Cheung, H.-K., Corbley, M. J., Zhang, X., Sun, L., Shan, F., Singh, J., Lee, W.-C., Albelda, S. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2389 · Cited by 113 · see citing works
USP11 augments TGFβ signalling by deubiquitylating ALK5
Al-Salihi, M. A., Herhaus, L., Macartney, T., & Sapkota, G. P. (2012) · Open Biology · doi:10.1098/rsob.120063 · Cited by 113 · see citing works
TGF Beta Inhibition for Cancer Therapy
Saunier, E. F., & Akhurst, R. J. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906778742460 · Cited by 112 · see citing works
Arginine Methylation Initiates BMP-Induced Smad Signaling
Xu, J., Wang, A. H., Osés-Prieto, J. A., Makhijani, K., Katsuno, Y., Pei, M., Yan, L., Zheng, Y. G., Burlingame, A. L., Brückner, K., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.004 · Cited by 108 · see citing works
Rodon, J. A., Carducci, M. A., Sepúlveda-Sánchez, J. M., Azaro, A., Calvo, E., Seoane, J., Braña, I., Sicart, E., Gueorguieva, I., Cleverly, A., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0192-4 · Cited by 108 · see citing works
Kovacs, R. J., Maldonado, G., Azaro, A., Fernández, M. S., Romero, F. L., Sepulveda-Sánchez, J. M., Corretti, M., Carducci, M., Dolan, M., Gueorguieva, I., et al. (2015) · Cardiovascular Toxicology · doi:10.1007/s12012-014-9297-4 · Cited by 108 · see citing works
Pathobiology of pulmonary arterial hypertension
Eddahibi, S., Morrell, N. W., d’Ortho, M., Naeije, R., & Adnot, S. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00081302 · Cited by 107 · see citing works
Modulation of GDF5/BRI‐b signalling through interaction with the tyrosine kinase receptor Ror2
Sammar, M., Stricker, S., Schwabe, G. C., Sieber, C., Hartung, A., Hanke, M., Oishi, I., Pohl, J., Minami, Y., Sebald, W., et al. (2004) · Genes to Cells · doi:10.1111/j.1365-2443.2004.00799.x · Cited by 104 · see citing works
Bone Morphogenetic Protein Receptor Type II C-Terminus Interacts with c-Src
Wong, W. K. P., Knowles, J. A., & Morse, J. H. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0103oc · Cited by 104 · see citing works
Endofin acts as a Smad anchor for receptor activation in BMP signaling
Shi, W., Chang, C., Nie, S., Xie, S., Wan, M., & Cao, X. (2007) · Journal of Cell Science · doi:10.1242/jcs.03400 · Cited by 104 · see citing works
Endoglin Differentially Modulates Antagonistic Transforming Growth Factor-β1 and BMP-7 Signaling
Scherner, O., Meurer, S. K., Tihaa, L., Gressner, A. M., & Weiskirchen, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611062200 · Cited by 102 · see citing works
Scaffidi, A. K., Petrovic, N., Moodley, Y. P., Fogel‐Petrovic, M., Kroeger, K. M., Seeber, R. M., Eidne, K. A., Thompson, P. J., & Knight, D. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403010200 · Cited by 101 · see citing works
Xia, Y. Y., Yu, P. B., Sidis, Y., Beppu, H., Bloch, K. D., Schneyer, A. L., & Lin, H. Y.-F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701679200 · Cited by 99 · see citing works
van Meeteren, L. A., Thorikay, M., Bergqvist, S., Pardali, E., Stampino, C. G., Hu‐Lowe, D. D., Goumans, M., & ten Dijke, P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338103 · Cited by 96 · see citing works
Transcriptional regulation of the TGF-β pseudoreceptor BAMBI by TGF-β signaling
Sekiya, T., Oda, T., Matsuura, K., & Akiyama, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.017 · Cited by 94 · see citing works
Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation
Bagarova, J., Vonner, A. J., Armstrong, K. A., Boergermann, J. H., Lai, C. S. C., Deng, D. Y., Beppu, H., Alfano, I., Filippakopoulos, P., Morrell, N. W., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01595-12 · Cited by 93 · see citing works
Cripto Binds Transforming Growth Factor β (TGF-β) and Inhibits TGF-β Signaling
Gray, P. C., Shani, G., Aung, K., Kelber, J. A., & Vale, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01168-06 · Cited by 93 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Derynck R, Miyazono K, ed. 2008. The TGF-b family. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Cited by
Sorted by citations
Transforming Growth Factor-β Signaling in Immunity and Cancer
Batlle, E., & Massagué, J. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.024 · Cited by 2,366 · see citing works
Transforming growth factor–β in tissue fibrosis
Frangogiannis, N. G. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190103 · Cited by 1,310 · see citing works
New insights into TGF-β/Smad signaling in tissue fibrosis
Hu, H.-H., Chen, D., Wang, Y., Feng, Y., Cao, G., Vaziri, N. D., & Zhao, Y. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.008 · Cited by 1,188 · see citing works
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
Hao, Y., Baker, D. A., & ten Dijke, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112767 · Cited by 1,155 · see citing works
TGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944 · see citing works
Cellular signalling by primary cilia in development, organ function and disease
Anvarian, Z., Mykytyn, K., Mukhopadhyay, S., Pedersen, L. B., & Christensen, S. T. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0116-9 · Cited by 845 · see citing works
TGF-β signaling in health and disease
Massagué, J., & Sheppard, D. (2023) · Cell · doi:10.1016/j.cell.2023.07.036 · Cited by 890 · see citing works
Contextual determinants of TGFβ action in development, immunity and cancer
David, C. J., & Massagué, J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0007-0 · Cited by 851 · see citing works
Tzavlaki, K., & Moustakas, A. (2020) · Biomolecules · doi:10.3390/biom10030487 · Cited by 816 · see citing works
Self-citationTGF-β1 Signaling and Tissue Fibrosis
Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800 · see citing works
Specificity, versatility, and control of TGF-β family signaling
Derynck, R., & Budi, E. H. (2019) · Science Signaling · doi:10.1126/scisignal.aav5183 · Cited by 785 · see citing works
TGF-β1 – A truly transforming growth factor in fibrosis and immunity
Lodyga, M., & Hinz, B. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.12.010 · Cited by 462 · see citing works
Novel therapies emerging in oncology to target the TGF‐β pathway
Kim, B.-G., Malek, E., Choi, S. H., Ignatz-Hoover, J. J., & Driscoll, J. J. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01053-x · Cited by 453 · see citing works
Targeting TGFβ signal transduction for cancer therapy
Liu, S., Ren, J., & ten Dijke, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00436-9 · Cited by 413 · see citing works
“Subsequently, the SMAD2/3–SMAD4 complex can translocate into the nucleus to activate or repress the expression of target genes.(55,56) SMAD7 is a target gene induced by TGFβ that encodes for a negative regulator of the TGFβ/SMAD signaling pathway by associating Mesenchymal tumor cells Fibroblasts Immune cells Endothel…”
BackgroundTGF-β Signaling in Cellular Senescence and Aging-Related Pathology
Tominaga, K., & Suzuki, H. I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205002 · Cited by 393 · see citing works
Overcoming TGFβ-mediated immune evasion in cancer
Tauriello, D. V. F., Sancho, E., & Batlle, E. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00413-6 · Cited by 377 · see citing works
TGF-β Signaling in Control of Cardiovascular Function
Goumans, M.-J., & ten Dijke, P. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022210 · Cited by 360 · see citing works
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Fabregat, I., & Caballero‐Díaz, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00357 · Cited by 352 · see citing works
Transforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 349 · see citing works
Liver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307 · see citing works
TGF ‐β as a driver of fibrosis: physiological roles and therapeutic opportunities
Budi, E. H., Schaub, J. R., Decaris, M. L., Turner, S., & Derynck, R. (2021) · The Journal of Pathology · doi:10.1002/path.5680 · Cited by 300 · see citing works
Pakshir, P., Noskovicova, N., Lodyga, M., Son, D. O., Schuster, R., Goodwin, A., Karvonen, H., & Hinz, B. (2020) · Journal of Cell Science · doi:10.1242/jcs.227900 · Cited by 293 · see citing works
Transforming Growth Factor-β Receptors and Smads: Regulatory Complexity and Functional Versatility
Budi, E. H., Duan, D., & Derynck, R. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.04.005 · Cited by 287 · see citing works
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
Fang, Z., Meng, Q., Xu, J., Wang, W., Zhang, B., Liu, J., Liang, C., Hua, J., Zhao, Y., Yu, X., et al. (2022) · 癌症:英文版 · doi:10.1002/cac2.12392 · Cited by 292 · see citing works
TGF-β Family Signaling in Mesenchymal DifferentiationPreprint
Grafe, I., Alexander, S., Peterson, J. R., Snider, T. N., Lévi, B., Lee, B., & Mishina, Y. M. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022202 · Cited by 272 · see citing works
The Role of the TGF-β Superfamily in Myocardial Infarction
Hanna, A., & Frangogiannis, N. G. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00140 · Cited by 253 · see citing works
TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
Hua, W., ten Dijke, P., Kostidis, S., Giera, M. A., & Hornsveld, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03398-6 · Cited by 237 · see citing works
Cancer drug resistance induced by EMT: novel therapeutic strategies
Rivas, J. D. L., Brozović, A., Izraely, S., Casas-Pais, A., Witz, I. P., & Figueroa, A. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03063-7 · Cited by 231 · see citing works
Single cell transcriptomics of human epidermis identifies basal stem cell transition states
Wang, S., Drummond, M. L., Guerrero-Juarez, C. F., Tarapore, E., MacLean, A. L., Stabell, A. R., Wu, S. C., Gutierrez, G., That, B. T., Benavente, C. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18075-7 · Cited by 218 · see citing works
TGF-&beta; family co-receptor function and signaling
Nickel, J., Ten Dijke, P., & Mueller, T. D. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx126 · Cited by 198 · see citing works
TGF-β Signaling and Resistance to Cancer Therapy
Zhang, M., Zhang, Y. Y., Chen, Y., Wang, J., Wang, Q., & Lu, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.786728 · Cited by 199 · see citing works
Implant Fibrosis and the Underappreciated Role of Myofibroblasts in the Foreign Body Reaction
Noskovicova, N., Hinz, B., & Pakshir, P. (2021) · Cells · doi:10.3390/cells10071794 · Cited by 184 · see citing works
TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies
Ong, C. H., Tham, C. L., Harith, H. H., Firdaus, N., & Israf, D. A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174510 · Cited by 189 · see citing works
EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation
Zhang, L., Qu, J., Qi, Y., Duan, Y., Huang, Y.-W., Zhou, Z., Li, P., Yao, J., Huang, B., Zhang, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30105-0 · Cited by 182 · see citing works
Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment
Gulley, J. L., Schlom, J., Barcellos‐Hoff, M. H., Wang, X., Seoane, J., Audhuy, F., Lan, Y., Dussault, I., & Moustakas, A. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13146 · Cited by 178 · see citing works
Self-citationTGF-beta signal transduction: biology, function and therapy for diseases
Tie, Y., Tang, F., Peng, D., Zhang, Y., & Shi, H. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00109-9 · Cited by 178 · see citing works
Neuraxial Cytokines in Pain States
dos Santos, G. G., Delay, L., Yaksh, T. L., & Corr, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03061 · Cited by 163 · see citing works
Carthy, J. M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25879 · Cited by 153 · see citing works
<p>Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor</p>
Bai, X., Yi, M., Jiao, Y., Chu, Q., & Wu, K. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s224013 · Cited by 153 · see citing works
The role of Smad signaling cascades in cardiac fibrosis
Hanna, A., Humeres, C., & Frangogiannis, N. G. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109826 · Cited by 132 · see citing works
Tuleta, I., & Frangogiannis, N. G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113904 · Cited by 137 · see citing works
TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
Lamora, A., Talbot, J., Mullard, M., Royer, B. B.-L., Rédiní, F., & Verrecchia, F. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5110096 · Cited by 131 · see citing works
Verrecchia, F., & Rédiní, F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00133 · Cited by 129 · see citing works
Targeting immunosuppression by TGF-β1 for cancer immunotherapy
de Streel, G., & Lucas, S. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114697 · Cited by 129 · see citing works
The role of small GTPases of the Rho/Rac family in TGF‐β‐induced EMT and cell motility in cancer
Ungefroren, H., Witte, D. P., & Lehnert, H. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24505 · Cited by 127 · see citing works
TGF-β and BMPR2 Signaling in PAH: Two Black Sheep in One Family
Rol, N., Kurakula, K., Happé, C. M., Bogaard, H. J., & Goumans, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092585 · Cited by 128 · see citing works
Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT
Sisto, M., Ribatti, D., & Lisi, S. (2021) · Biomolecules · doi:10.3390/biom11020310 · Cited by 127 · see citing works
The role of TGF-β superfamily signaling in neurological disorders
Kashima, R., & Hata, A. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx124 · Cited by 126 · see citing works
Feedback regulation of TGF-β signaling
Yan, X., Xiong, X., & Chen, Y. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx129 · Cited by 127 · see citing works
Humeres, C. D., Shinde, A. V., Hanna, A., Alex, L., Hernández, S. C., Li, R., Chen, B., Conway, S. J., & Frangogiannis, N. G. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146926 · Cited by 126 · see citing works
Wu, B., Zhang, S., Guo, Z., Bi, Y., Zhou, M., Li, P., Seyedsadr, M., Xu, X., Li, J., Markovic‐Plese, S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2020.12.010 · Cited by 122 · see citing works
Sánchez‐Duffhues, G., Williams, E., Goumans, M., Heldin, C., & ten Dijke, P. (2020) · Bone · doi:10.1016/j.bone.2020.115472 · Cited by 119 · see citing works
Self-citationDeregulated TGF-β/BMP Signaling in Vascular Malformations
Cunha, S. I., Magnusson, P. U., Dejana, E., & Lampugnani, M. G. (2017) · Circulation Research · doi:10.1161/circresaha.117.309930 · Cited by 118 · see citing works
Lineage-specific events underlie aortic root aneurysm pathogenesis in Loeys-Dietz syndrome
MacFarlane, E. G., Parker, S. J., Shin, J. Y., Ziegler, S. G., Creamer, T. J., Bagirzadeh, R., Bedja, D., Chen, Y., Calderón, J. F., Weissler, K. A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123547 · Cited by 117 · see citing works
TGF-β Family Signaling in Connective Tissue and Skeletal DiseasesPreprint
MacFarlane, E. G., Haupt, J., Dietz, H. C., & Shore, E. M. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022269 · Cited by 119 · see citing works
Mancarella, S., Cigliano, A., Chieti, A., Giannelli, G., & Dituri, F. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1676121 · Cited by 114 · see citing works
Feron, R., Zahm, M., Cabau, C., Klopp, C., Lopez‐Roques, C., Bouchez, O., Eché, C., Valière, S., Donnadieu, C., Haffray, P., et al. (2020) · Molecular Ecology Resources · doi:10.1111/1755-0998.13133 · Cited by 108 · see citing works
The universe of galectin-binding partners and their functions in health and disease
Troncoso, M. F., Elola, M. T., Blidner, A. G., Sarrias, L., Espelt, M. V., & Rabinovich, G. A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105400 · Cited by 116 · see citing works
Tecalco-Cruz, Á. C., Ríos-López, D. G., Vázquez‐Victorio, G., Rosales-Alvarez, R. E., & Macías‐Silva, M. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0015-8 · Cited by 113 · see citing works
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111 · see citing works
Kapoor, M., & Chinnathambi, S. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02751-8 · Cited by 114 · see citing works
Sakai, S., Ohhata, T., Kitagawa, K., Uchida, C., Aoshima, T., Niida, H., Suzuki, T., Inoue, Y., Miyazawa, K., & Kitagawa, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3210 · Cited by 100 · see citing works
Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer
Zhang, J., ten Dijke, P., Wuhrer, M., & Zhang, T. (2020) · Protein & Cell · doi:10.1007/s13238-020-00741-7 · Cited by 99 · see citing works
Current perspectives on inhibitory SMAD7 in health and disease
van Capelle, C. D. C., Spit, M., & ten Dijke, P. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1828260 · Cited by 99 · see citing works
Epithelial-mesenchymal transition: Insights into nickel-induced lung diseases
Lee, H., Jose, C. C., & Cuddapah, S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.020 · Cited by 102 · see citing works
Mechanistic insight into contextual TGF-β signaling
Zhang, Y. E. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.10.001 · Cited by 94 · see citing works
Signaling cascades in the failing heart and emerging therapeutic strategies
He, X., Du, T., Long, T., Liao, X., Dong, Y., & Huang, Z. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00972-6 · Cited by 105 · see citing works
Zhang, G., Gao, Z.-X., Guo, X., Ma, R., Wang, X., Zhou, P., Li, C., Tang, Z., Zhao, R., & Gao, P. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166224 · Cited by 94 · see citing works
Hong, Q., Cai, H., Zhang, L., Li, Z., Zhong, F., Ni, Z., Cai, G., Chen, X., He, C., & Lee, K. (2021) · Kidney International · doi:10.1016/j.kint.2021.10.023 · Cited by 92 · see citing works
Patsalos, A., Halász, L., Medina-Serpas, M. A., Berger, W. K., Dániel, B., Tzerpos, P., Kiss, M., Nagy, G., Fischer, C., Simándi, Z., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210420 · Cited by 89 · see citing works
TGFβ family signaling and development
Jia, S., & Meng, A. (2021) · Development · doi:10.1242/dev.188490 · Cited by 91 · see citing works
Ning, J., Zhao, Y. C., Ye, Y., & Yu, J. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.033 · Cited by 89 · see citing works
The Role of TGF-β in Bone Metastases
Trivedi, T., Pagnotti, G. M., Guise, T. A., & Mohammad, K. S. (2021) · Biomolecules · doi:10.3390/biom11111643 · Cited by 91 · see citing works
Zheng, S., Long, J., Liu, Z., Tao, W., & Wang, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041154 · Cited by 85 · see citing works
TGF‐β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation
Baik, J. E., Park, H. J., Kataru, R. P., Savetsky, I. L., Ly, C. L., Shin, J., Encarnacion, E. M., Cavali, M., Klang, M. G., Riedel, E., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.758 · Cited by 87 · see citing works
Targeting Nestin+ hepatic stellate cells ameliorates liver fibrosis by facilitating TβRI degradation
Chen, H., Cai, J., Wang, J., Qiu, Y., Jiang, C., Wang, Y., Wang, Y., Yi, C., Lv, G., Pan, L., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.016 · Cited by 82 · see citing works
TGFβ signaling networks in ovarian cancer progression and plasticity
Kumari, A., Shonibare, Z., Monavarian, M., Arend, R. C., Lee, N. Y., Inman, G. J., & Mythreye, K. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10077-z · Cited by 76 · see citing works
Li, X.-S., Wu, Y., & Tian, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214436 · Cited by 82 · see citing works
Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Zarrin, V., Moghadam, E. R., Hashemi, F., Makvandi, P., Samarghandian, S., Khan, H. Z., Hashemi, F., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585413 · Cited by 79 · see citing works
Physical and functional interactome atlas of human receptor tyrosine kinases
Salokas, K., Öhman, T., Liu, X., Chowdhury, I. M., Gawriyski, L. M., Keskitalo, S., & Varjosalo, M. T. (2022) · EMBO Reports · doi:10.15252/embr.202154041 · Cited by 71 · see citing works
Trophoblast Differentiation: Mechanisms and Implications for Pregnancy Complications
Lawless, L., Qin, Y., Xie, L., & Zhang, K. (2023) · Nutrients · doi:10.3390/nu15163564 · Cited by 78 · see citing works
Nishida, J., Miyazono, K., & Ehata, S. (2018) · Oncogene · doi:10.1038/s41388-017-0084-0 · Cited by 78 · see citing works
Feng, F., Li, N., Cheng, P., Zhang, H., Wang, H., Wang, Y., & Wang, W. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109586 · Cited by 76 · see citing works
Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
van den Bulk, J., de Miranda, N. F. C. C., & ten Dijke, P. (2021) · Clinical Science · doi:10.1042/cs20201236 · Cited by 75 · see citing works
Cell-Tissue Interaction: The Biomimetic Approach to Design Tissue Engineered Biomaterials
Nitti, P., Narayanan, A., Pellegrino, R., Villani, S., Madaghiele, M., & Demitri, C. (2023) · Bioengineering · doi:10.3390/bioengineering10101122 · Cited by 75 · see citing works
BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration
Herrera, B. M., Addante, A., & Sánchez, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010039 · Cited by 74 · see citing works
The role of TGF-β and its crosstalk with RAC1/RAC1b signaling in breast and pancreas carcinoma
Melzer, C., Hass, R., von der Ohe, J., Lehnert, H., & Ungefroren, H. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0175-0 · Cited by 73 · see citing works
Duan, D., & Derynck, R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005763 · Cited by 72 · see citing works
Structural perspective of BMP ligands and signaling
Gipson, G. R., Goebel, E. J., Hart, K. N., Kappes, E. C., Kattamuri, C., McCoy, J. C., & Thompson, T. B. (2020) · Bone · doi:10.1016/j.bone.2020.115549 · Cited by 72 · see citing works
Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities
O’Reilly, E., Zeinabad, H. A., & Szegezdi, É. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100850 · Cited by 72 · see citing works
Targeting type I collagen for cancer treatment
Shi, R., Zhang, Z., Zhu, A.-K., Xiong, X., Zhang, J., Xu, J., Sy, M., & Li, C. (2022) · International Journal of Cancer · doi:10.1002/ijc.33985 · Cited by 71 · see citing works
Signaling pathways in liver cancer: pathogenesis and targeted therapy
Xue, Y., Ruan, Y., Wang, Y., Xiao, P., & Xu, J. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00184-0 · Cited by 81 · see citing works
Contextual Regulation of TGF-β Signaling in Liver Cancer
Tu, S., Huang, W., Huang, C., Luo, Z., & Yan, X. (2019) · Cells · doi:10.3390/cells8101235 · Cited by 70 · see citing works
Merčnik, M. H., Schliefsteiner, C., Sánchez‐Duffhues, G., & Wadsack, C. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmae007 · Cited by 72 · see citing works
Liu, H., Sun, M., Wu, N., Liu, B., Liu, Q., & Fan, X. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.1060 · Cited by 66 · see citing works
TGF-β Pathway in Salivary Gland Fibrosis
Zhang, X., Yun, J. S., Han, D., Yook, J. I., Kim, H. S., & Cho, E. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239138 · Cited by 63 · see citing works
TGFβ signalling acts as a molecular brake of myoblast fusion
Melendez, J., Sieiro, D., Salgado, D., Morin, V., Dejardin, M.-J., Zhou, C., Mullen, A. C., & Marcelle, C. (2021) · Nature Communications · doi:10.1038/s41467-020-20290-1 · Cited by 66 · see citing works
Donker, L., Houtekamer, R. M., Vliem, M. J., Sipieter, F., Canever, H., Gómez‐González, M., Padrós, M. B., Pannekoek, W., Trepat, X., Borghi, N., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111475 · Cited by 62 · see citing works
Watabe, T., Takahashi, K., Pietras, K., & Yoshimatsu, Y. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.04.007 · Cited by 62 · see citing works
Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
Suriyamurthy, S., Baker, D. A., ten Dijke, P., & Iyengar, P. V. (2019) · Cancers · doi:10.3390/cancers11050726 · Cited by 62 · see citing works
- Authors
- Heldin, C.-H., & Moustakas, A.
- Affiliations
- Uppsala University (SE)
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-08
- Volume
- 8
- Issue
- 8
- Pages
- a022053
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC4968163
- OpenAlex
- W2503685584
- Cited by
- 711
- References
- 287
- Citations by year
- 2026: 60 · 2025: 76 · 2024: 95 · 2023: 72 · 2022: 103 · 2021: 107 · 2020: 72 · 2019: 57 · 2018: 30 · 2017: 33 · 2016: 6
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ludwig Institute for Cancer Research
- European Commission
- Cancerfonden
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- TGF-beta signaling, TGF-beta receptor, receptor activation, receptor stability, post-translational modification, phosphorylation, ubiquitination, SUMOylation, neddylation, MAPK signaling, Src kinase, phosphatidylinositol 3-kinase, Rho GTPases, transcription factors
- MeSH terms
- Cell Nucleus, Cytoplasm, Endocytosis, Humans, Membrane Proteins, Phosphorylation, Signal Transduction, Up-Regulation, Transforming Growth Factor beta, Receptors, Transforming Growth Factor beta, Protein Transport, MicroRNAs, Sumoylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review